SPOTLIGHT -
Immediate past president Eva Chalas, MD, discusses the top sessions, events and presentations to watch for at ACOG's annual meeting.
Secnidazole shows promise for recurrent BV treatment in new clinical trial
A recent study presented at ACOG 2025 highlights the potential of once-weekly secnidazole oral granules as an effective long-term therapy for recurrent bacterial vaginosis.
Read More
Expanded UNITY panel aims to improve fetal risk screening across diverse populations
New 14-gene test allows early, precise assessment without partner samples.
2025 ACOG Annual Clinical and Scientific Meeting: What you missed
Find out what you may have missed at the 2025 ACOG ACSM.
Use of hair, cosmetic products linked to increased phthalate exposure in pregnancy
Research presented at the 2025 ACOG ACSM highlighted the potential risks tied to personal care product use among African American pregnant patients.
Post-Dobbs abortion access in North Carolina shows delays, increased out-of-state travel, and disparities
In an abstract featured at the 2025 ACOG ACSM, researchers found that after Dobbs, North Carolina saw more out-of-state abortion patients, longer wait times, and increased racial disparities.
Evaluating diagnostic tools for adnexal masses in novice hands
A comparison of 4 ultrasound-based algorithms demonstrated strong performance, with nuanced implications for clinical practice, according to a new study presented at the 2025 ACOG ACSM.